cis-3,4-Dihydroxy-beta-Ionone

Catalog No.: 
ACHDUD483
CAS No.: 
875666-39-0
Molecular Formula: 
C13H20O3
Molecular Weight: 
224.30
cis-3,4-Dihydroxy-beta-Ionone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$338.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namecis-3,4-Dihydroxy-beta-Ionone
IUPAC Name(E)-4-((3R,4S)-3,4-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one
Molecular FormulaC13H20O3
Molecular Weight224.30
SMILESCC(/C=C/C1=C(C)[C@@H](O)[C@@H](O)CC1(C)C)=O
InChI KeyFXRGLHAKDUTPCV-CYLBZQBVSA-N
Synonymcis-3,4-Dihydroxy-β-ionone;(3E)-4-[(3R,4S)-3,4-Dihydroxy-2,6,6-trimethyl-1-cyclohexen-1-yl]-3-buten-2-one;cis-3,4-Dihydroxy-beta-ionone;3-Buten-2-one, 4-[(3R,4S)-3,4-dihydroxy-2,6,6-trimethyl-1-cyclohexen-1-yl]-, (3E)-;4-(3,4-Dihydroxy-2,6,6-trimethylcyclohexen-1-yl)but-3-en-2-one
CAS No.875666-39-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACHDUD483 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBWQR164 route compound structure diagram
    ACBWQR1641439-36-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHDUD483 route product structure diagram
    ACHDUD483875666-39-0
Inquiry

2. ACHDUD483 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHDUD483 route product structure diagram
    ACHDUD483875666-39-0
Inquiry

3. ACHDUD483 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHDUD483 route product structure diagram
    ACHDUD483875666-39-0
Inquiry

Comments (0)